Limited Penetration of Lopinavir and Ritonavir in the Genital Tract of Men Infected with HIV-1 in Brazil
Authors:
- Rita C. E. EstrelaRERita C. E. Estrela
- Guilherme Suarez-KurtzGSGuilherme Suarez-Kurtz
- Mauro SchechterMSMauro Schechter
- José Cerbino-NetoJCJosé Cerbino-Neto
- Paulo F. BarrosoPBPaulo F. Barroso
- 1 April 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 28 (2) , 175-179
Abstract
The concentrations of lopinavir and ritonavir in seminal and blood plasma and the seminal human immunodeficiency virus (HIV) viral load were quantified by HPLC and the Nuclisens® assay, respectively, in a cross-sectional study of 16 HIV-1–infected Brazilian men under stable treatment with a lopinavir/ritonavir containing antiretroviral regimen. Semen and blood samples were collected on 2 occasions: at 6 to 60 minutes before (“trough”), and 5 to 6 hours after (“peak”) ingestion of regular doses of lopinavir/ritonavir. Median seminal lopinavir levels were 120.6 ng/mL (range, <20–1481.8 ng/mL) and 233.1 ng/mL (range, 48.4–1133.4 ng/mL) at trough and peak points, respectively. The corresponding values for ritonavir were 9.2 ng/mL (range, <5–47 ng/mL) and 17.1 ng/mL (range, 6.6–66.7 ng/mL). The median concentrations of lopinavir and ritonavir in semen were, respectively, 1.9% to 3% and 3.7% to 4.4% of those measured in blood plasma samples collected within 30 minutes. HIV-1 viral load was detectable in the semen of 2 and in the blood of 6 of 16 patients. These results may have implications for drug-resistant HIV-1 evolution and transmission.Keywords
This publication has 27 references indexed in Scilit:
- Pharmacogenomics in admixed populationsTrends in Pharmacological Sciences, 2005
- Decreased HIV Transmission after a Policy of Providing Free Access to Highly Active Antiretroviral Therapy in TaiwanThe Journal of Infectious Diseases, 2004
- P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and TherapyAntimicrobial Agents and Chemotherapy, 2004
- Thiopurine methyltransferase phenotypes and genotypes in BraziliansPharmacogenetics, 2003
- LopinavirAIDS, 2003
- Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2003
- Therapeutic Drug Monitoring of HIV Protease Inhibitors Using High-Performance Liquid Chromatography With Ultraviolet or Photodiode Array DetectionTherapeutic Drug Monitoring, 2001
- Antiretroviral drug concentrations in semen of HIV-1 infected menSexually Transmitted Infections, 2001
- Nucleoside Analogues Achieve High Concentrations in Seminal Plasma: Relationship between Drug Concentration and Virus BurdenThe Journal of Infectious Diseases, 1999
- RitonavirClinical Pharmacokinetics, 1998